LCTX logo

Lineage Cell Therapeutics (LCTX) Interest Expense

Annual Interest Expense

N/A

31 December 2023

All-time High

$1.65 M
LCTX annual interest expense is currently at an all-time high
Annual Total Expenses$33.68 M
LCTX annual total expenses is $33.68 million
Annual Operating Expenses$33.01 M
LCTX annual total operating expenses is $33.01 million
Annual Cost Of Goods Sold$671.00 K
LCTX annual cost of goods sold is $671.00 thousand

LCTX Interest Expense Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Interest Expense

N/A

30 September 2024

All-time High

$653.70 K
LCTX quarterly interest expense is currently at an all-time high
Quarterly Total Expenses$7.62 M
LCTX quarterly total expenses is $7.62 million
Quarterly Operating Expenses$7.58 M
LCTX quarterly total operating expenses is $7.58 million
Quarterly Cost Of Goods Sold$38.00 K
LCTX quarterly cost of goods sold is $38.00 thousand

LCTX Quarterly Interest Expense Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM Interest Expense

N/A

30 September 2024

All-time High

$1.95 M
LCTX TTM interest expense is currently at an all-time high
Annual Total Expenses$33.68 M
LCTX annual total expenses is $33.68 million
Annual Operating Expenses$33.01 M
LCTX annual total operating expenses is $33.01 million
TTM Cost Of Goods Sold$436.00 K
LCTX TTM cost of goods sold is $436.00 thousand

LCTX TTM Interest Expense Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

LCTX Interest Expense Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year---
3 y3 years---
5 y5 years---

LCTX Interest Expense High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years
5 y5 years
alltimeall time

Lineage Cell Therapeutics Interest Expense History

DateAnnualQuarterlyTTM
June 2010
-
$100.00(-100.0%)
$981.20 K(-49.8%)
Dec 2009
$1.65 M
$327.40 K(-49.9%)
$1.95 M(+20.1%)
Sept 2009
-
$653.70 K(+78.9%)
$1.63 M(+67.1%)
DateAnnualQuarterlyTTM
June 2009
-
$365.50 K(-39.9%)
$973.50 K(+60.1%)
Mar 2009
-
$608.00 K
$608.00 K
Dec 2008
$965.80 K
-
-

FAQ

  • What is the all time high annual interest expense for Lineage Cell Therapeutics?
  • What is the all time high quarterly interest expense for Lineage Cell Therapeutics?
  • What is the all time high TTM interest expense for Lineage Cell Therapeutics?

What is the all time high annual interest expense for Lineage Cell Therapeutics?

Lineage Cell Therapeutics all-time high annual interest expense is $1.65 M

What is the all time high quarterly interest expense for Lineage Cell Therapeutics?

Lineage Cell Therapeutics all-time high quarterly interest expense is $653.70 K

What is the all time high TTM interest expense for Lineage Cell Therapeutics?

Lineage Cell Therapeutics all-time high TTM interest expense is $1.95 M